Indofarma Tbk Current Valuation vs. Total Debt

INAF Stock  IDR 126.00  0.00  0.00%   
Taking into consideration Indofarma Tbk's profitability measurements, Indofarma Tbk may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Indofarma Tbk's ability to earn profits and add value for shareholders.
For Indofarma Tbk profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Indofarma Tbk to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Indofarma Tbk utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Indofarma Tbk's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Indofarma Tbk over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Please note, there is a significant difference between Indofarma Tbk's value and its price as these two are different measures arrived at by different means. Investors typically determine if Indofarma Tbk is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Indofarma Tbk's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Indofarma Tbk Total Debt vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Indofarma Tbk's current stock value. Our valuation model uses many indicators to compare Indofarma Tbk value to that of its competitors to determine the firm's financial worth.
Indofarma Tbk is considered the number one company in current valuation category among its peers. It also is considered the number one company in total debt category among its peers making up about  0.13  of Total Debt per Current Valuation. The ratio of Current Valuation to Total Debt for Indofarma Tbk is roughly  7.98 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Indofarma Tbk's earnings, one of the primary drivers of an investment's value.

Indofarma Current Valuation vs. Competition

Indofarma Tbk is considered the number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 36.97 Trillion. Indofarma Tbk holds roughly 3.17 Trillion in current valuation claiming about 9% of equities under Health Care industry.

Indofarma Total Debt vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Indofarma Tbk

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
3.17 T
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Indofarma Tbk

Total Debt

 = 

Bonds

+

Notes

 = 
397.52 B
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

Indofarma Total Debt vs Competition

Indofarma Tbk is considered the number one company in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 5.71 Trillion. Indofarma Tbk holds roughly 397.52 Billion in total debt claiming about 7% of equities under Health Care industry.
Total debt  Workforce  Revenue  Capitalization  Valuation

Indofarma Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Indofarma Tbk. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Indofarma Tbk position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Indofarma Tbk's important profitability drivers and their relationship over time.

Use Indofarma Tbk in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Indofarma Tbk position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indofarma Tbk will appreciate offsetting losses from the drop in the long position's value.

Indofarma Tbk Pair Trading

Indofarma Tbk Pair Trading Analysis

The ability to find closely correlated positions to Indofarma Tbk could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Indofarma Tbk when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indofarma Tbk - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indofarma Tbk to buy it.
The correlation of Indofarma Tbk is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indofarma Tbk moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indofarma Tbk moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Indofarma Tbk can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Indofarma Tbk position

In addition to having Indofarma Tbk in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Recycling Thematic Idea Now

Recycling
Recycling Theme
West management companies as well as entities specializing in pollution control and recycling. The Recycling theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recycling Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Indofarma Stock

To fully project Indofarma Tbk's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Indofarma Tbk at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Indofarma Tbk's income statement, its balance sheet, and the statement of cash flows.
Potential Indofarma Tbk investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Indofarma Tbk investors may work on each financial statement separately, they are all related. The changes in Indofarma Tbk's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Indofarma Tbk's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.